<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03476980</url>
  </required_header>
  <id_info>
    <org_study_id>PREMOD2 Follow-Up</org_study_id>
    <nct_id>NCT03476980</nct_id>
  </id_info>
  <brief_title>Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping)</brief_title>
  <acronym>PREMOD2FU</acronym>
  <official_title>Two Year Developmental Follow-up for Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sharp HealthCare</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sharp Mary Birch Hospital for Women &amp; Newborns</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Providence Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College Cork</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Ulm</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Christiana Care Health Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Thrasher Research Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sharp Grossmont Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Mississippi Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sharp HealthCare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An extension of the PREMOD2 trial, the PREMOD2 Follow-Up trial will evaluate the
      neurodevelopmental outcomes at 22-26 months corrected age of preterm children who received
      UCM or DCC.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The PREMOD2 Follow-up trial will examine the difference in early childhood neurodevelopmental
      outcomes of subjects enrolled in the PREMOD2 umbilical cord milking (UCM) vs. delayed cord
      clamping (DCC) trial, using standardized neurologic and developmental assessments at 22-26
      months corrected age.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 6, 2019</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Neurodevelopmental assessments will be done at 2 years of corrected age (22-26 months) for subjects who were randomized at birth to receive either delayed cord clamping or umbilical cord milking as part of the PREMOD2 trial.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Neurodevelopmental providers will be blinded to the randomization of the toddler during the examination.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Developmental Outcome</measure>
    <time_frame>22-26 months corrected gestational age</time_frame>
    <description>Bayley Scales of Infant Development, 3rd or 4th Ed. Composite Score (cognitive 55-145, language 45-155, motor 45-155; higher scores are better)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Moderate/Severe Neurodevelopmental Impairment</measure>
    <time_frame>22-26 months corrected gestational age</time_frame>
    <description>Defined having at least one of the following: a cognitive score &lt;70, GMFCS greater or equal 2, blindness (vision &lt;20/200), or hearing impairment interfering with the ability to communicate with amplification.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mild Neurodevelopmental Impairment</measure>
    <time_frame>22-26 months corrected gestational age</time_frame>
    <description>Defined having at least one of the following: a cognitive score 70-84, GMFCS =1, unilateral blindness (vision &lt;20/200 in only one eye), or hearing impairment which does not interfere with the ability to communicate.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gross Motor Function Classification System Scale (GMFCS)</measure>
    <time_frame>22-26 months corrected gestational age</time_frame>
    <description>The GMFCS is a validated system used to describe the severity of motor dysfunction. Scale measured from Level 0-5 with Level 0 being normal and Level 5 being the worst score. Measures ability to walk, sit, head control, voluntary movements and postures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral Palsy</measure>
    <time_frame>22-26 months corrected gestational age</time_frame>
    <description>Classified as None, Mild, Moderate or Severe based on GMFCS score; No CP = GMFCS Level 0, Mild CP = GMFCS Level 1, Moderate CP = GMFCS Levels 2-3, Severe CP = GMFCS Levels 4-5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Developmental Outcomes in infants born at 23 to 27 weeks GA who received UCM or DCC</measure>
    <time_frame>22-26 months corrected gestational age</time_frame>
    <description>BSID Cognitive, Language &amp; Motor composite scores in infants 23-27 weeks GA. (cognitive 55-145, language 45-155, motor 45-155; higher scores are better)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any grade IVH in premature newborns 23 - 32+6 weeks GA who received UCM or DCC by mode of delivery (C-Section vs vaginal delivery)</measure>
    <time_frame>From birth through hospital discharge, up to 6 months corrected gestational age (CGA)</time_frame>
    <description>Any IVH grade from 1 to grade 4, higher grade is worse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death in premature newborns 23 - 32+6 weeks GA who received UCM or DCC by mode of delivery (C-Section vs vaginal delivery)</measure>
    <time_frame>From birth through hospital discharge, up to 6 months corrected gestational age (CGA)</time_frame>
    <description>Death</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Exploratory, hypothesis-generating</measure>
    <time_frame>From birth through hospital discharge, up to 6 months corrected gestational age (CGA)</time_frame>
    <description>Any grade IVH, from 1 to 4 (higher is worse)</description>
  </other_outcome>
  <other_outcome>
    <measure>Exploratory, hypothesis-generating</measure>
    <time_frame>4 hours of life +/- 2 hours</time_frame>
    <description>Hemoglobin or Hematocrit at 4 hours of age</description>
  </other_outcome>
  <other_outcome>
    <measure>Exploratory, hypothesis-generating</measure>
    <time_frame>In the first 10 minutes of life</time_frame>
    <description>Delivery room interventions received: positive pressure ventilation, continuous positive airway pressure, intubation, chest compressions and medications</description>
  </other_outcome>
  <other_outcome>
    <measure>Exploratory, hypothesis-generating</measure>
    <time_frame>In the first 24 hours of life</time_frame>
    <description>Blood pressures in the first 24 hours of life: on admission, 6, 12, 18 and 24 hours of life</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Neurodevelopmental Abnormality</condition>
  <arm_group>
    <arm_group_label>Randomized to Umbilical Cord Milking at birth</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Milking the umbilical cord towards the infant at a speed of 20cm/2seconds at birth.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Randomized to Delayed Cord Clamping at birth</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Delayed clamping of the umbilical cord at birth.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Randomized to Umbilical Cord Milking at birth</intervention_name>
    <description>The subjects in this group were randomized to UCM X4 at birth. This procedure infuses a placental transfusion of blood by milking the umbilical cord towards the infant at birth.</description>
    <arm_group_label>Randomized to Umbilical Cord Milking at birth</arm_group_label>
    <other_name>UCM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Randomized to Delayed Cord Clamping at birth</intervention_name>
    <description>The subjects in this group were randomized to DCC at birth. At delivery, the obstetrician was instructed to delay clamping of the umbilical cord for 60 seconds.</description>
    <arm_group_label>Randomized to Delayed Cord Clamping at birth</arm_group_label>
    <other_name>DCC</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children enrolled in the PREMOD2 non-inferiority trial at birth who survive to 2 years
             corrected age.

        Exclusion Criteria:

          -  Children enrolled in the PREMOD2 non-inferiority trial at birth who did not survive or
             are lost to follow-up.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Months</minimum_age>
    <maximum_age>26 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anup Katheria, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sharp Mary Birch Hospital for Women &amp; Newborns</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anup Katheria, MD</last_name>
    <phone>858 939-4170</phone>
    <email>anup.katheria@sharp.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jane Steen, RN</last_name>
    <phone>858 939-4114</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294-0004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wally Carlo, MD</last_name>
      <email>wcarlo@peds.uab.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Loma Linda Medical Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92350</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Farha Vora, MD</last_name>
      <email>FVora@llu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sharp Grossmont Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>91942</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Fulford, MD</last_name>
      <email>kevin.fulford@sharp.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sharp Mary Birch Hospital for Women and Newborns</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yvonne Vaucher, MD</last_name>
      <email>yvaucher@ucsd.edu</email>
    </contact>
    <contact_backup>
      <last_name>Anup Katheria, MD</last_name>
      <email>anup.katheria@sharp.com</email>
    </contact_backup>
    <investigator>
      <last_name>Anup Katheria, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Christiana Care</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19718</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shazia Bhat, MD</last_name>
      <email>SBhat@ChristianaCare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Karam, MD</last_name>
      <email>skaram@umc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Rachael Morris, MD</last_name>
      <email>rmorris@umc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Providence St. Vincent Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225-6603</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Raddish, MD</last_name>
      <email>Michele.Raddish@providence.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Magee-Womens Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sue Beers, PhD</last_name>
      <email>beerssr@upmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Clark, MD</last_name>
      <email>erin.clark@hsc.utah.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tara DuPont, MD</last_name>
      <email>tara.dupont@hsc.utah.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Governors of University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2R3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Hicks, MD</last_name>
      <email>matt.hicks@ahs.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of ULM</name>
      <address>
        <city>Ulm</city>
        <state>Baden-Wurttemberg</state>
        <zip>89075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jochen Essers, MD</last_name>
      <email>Jochen.Essers@uniklinik-ulm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cork University Maternity Hospital</name>
      <address>
        <city>Cork</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eugene Dempsey, MD</last_name>
      <email>G.Dempsey@ucc.ie</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Germany</country>
    <country>Ireland</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Katheria A, Garey D, Truong G, Akshoomoff N, Steen J, Maldonado M, Poeltler D, Harbert MJ, Vaucher YE, Finer N. A Randomized Clinical Trial of Umbilical Cord Milking vs Delayed Cord Clamping in Preterm Infants: Neurodevelopmental Outcomes at 22-26 Months of Corrected Age. J Pediatr. 2018 Mar;194:76-80. doi: 10.1016/j.jpeds.2017.10.037. Epub 2017 Dec 12.</citation>
    <PMID>29246467</PMID>
  </reference>
  <reference>
    <citation>Katheria AC, Truong G, Cousins L, Oshiro B, Finer NN. Umbilical Cord Milking Versus Delayed Cord Clamping in Preterm Infants. Pediatrics. 2015 Jul;136(1):61-9. doi: 10.1542/peds.2015-0368.</citation>
    <PMID>26122803</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>March 19, 2018</study_first_submitted>
  <study_first_submitted_qc>March 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2018</study_first_posted>
  <last_update_submitted>December 23, 2019</last_update_submitted>
  <last_update_submitted_qc>December 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neurodevelopmental impairment, prematurity</keyword>
  <keyword>Disability</keyword>
  <keyword>Umbilical cord milking</keyword>
  <keyword>Delayed cord clamping</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be made available per NICHD requirements (National Institute of Child Health and Human Development).</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>2 years after primary publication</ipd_time_frame>
    <ipd_access_criteria>An archived dataset with documentation will be made available for additional uses by outside investigators, in collaboration with the study investigators.</ipd_access_criteria>
    <ipd_url>http://clinicaltrials.gov</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

